Search by Drug Name or NDC
NDC 00904-6921-46 Ranitidine 75 mg/1 Details
Ranitidine 75 mg/1
Ranitidine is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by MAJOR PHARMACEUTICALS. The primary component is RANITIDINE HYDROCHLORIDE.
Product Information
| NDC | 00904-6921 |
|---|---|
| Product ID | 0904-6921_f2d75d05-d8ce-4166-19a9-e9b0265c99a7 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Ranitidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ranitidine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/1 |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Labeler Name | MAJOR PHARMACEUTICALS |
| Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075294 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00904-6921-46 (00904692146)
| NDC Package Code | 0904-6921-46 |
|---|---|
| Billing NDC | 00904692146 |
| Package | 1 BOTTLE in 1 CARTON (0904-6921-46) / 30 TABLET in 1 BOTTLE |
| Marketing Start Date | 2019-05-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |